Related references
Note: Only part of the references are listed.The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Eytan M. Stein et al.
BLOOD (2018)
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1-and C/EBPα-dependent enhancers in AML
Monica Cusan et al.
BLOOD (2018)
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
Yong Yu et al.
CANCER CELL (2018)
The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma
Ana Banito et al.
CANCER CELL (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing
Joo-Young Kang et al.
FASEB JOURNAL (2018)
High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma
Philip Eliades et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Antoine Italiano et al.
LANCET ONCOLOGY (2018)
The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells
Gundula Streubel et al.
MOLECULAR CELL (2018)
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Mikkel Staberg et al.
MOLECULAR ONCOLOGY (2018)
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs
Malgorzata Gozdecka et al.
NATURE GENETICS (2018)
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
Lu Wang et al.
NATURE MEDICINE (2018)
The protective role of DOT1L in UV-induced melanomagenesis
Bo Zhu et al.
NATURE COMMUNICATIONS (2018)
Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells
Ryusuke Yamamoto et al.
Oncotarget (2018)
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells
Yoshinori Ishikawa et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
Huairui Yuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma
Sebastian Trousil et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
Ying Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers
N. Sugino et al.
LEUKEMIA (2017)
BIX-01294 inhibits oncoproteins NSD1, NSD2 and NSD3
Masayo Morishita et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia
Carly T. Campbell et al.
MOLECULAR CANCER THERAPEUTICS (2017)
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Wei Qi et al.
NATURE CHEMICAL BIOLOGY (2017)
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
Kenneth D. Bromberg et al.
NATURE CHEMICAL BIOLOGY (2017)
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
Simon Papillon-Cavanagh et al.
NATURE GENETICS (2017)
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
Suraj Peri et al.
NATURE COMMUNICATIONS (2017)
ASH1L histone methyltransferase regulates the handoff between damage recognition factors in global-genome nucleotide excision repair
Chiara Balbo Pogliano et al.
NATURE COMMUNICATIONS (2017)
The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice
Gang Li et al.
SCIENTIFIC REPORTS (2017)
NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Kevin Brennan et al.
SCIENTIFIC REPORTS (2017)
EZH2 inhibitors in immunotherapy of melanoma
Peter Hersey et al.
CANCER RESEARCH (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
Anthony Tumber et al.
CELL CHEMICAL BIOLOGY (2017)
Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma
Deepanwita Sengupta et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
H3K27 Demethylase JMJD3 Employs the NF-kappa B and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Woo-Yong Park et al.
CANCER RESEARCH (2016)
Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells
Xifeng Xiong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1
Tae-Dong Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Structural analysis of human KDM5B guides histone demethylase inhibitor development
Catrine Johansson et al.
NATURE CHEMICAL BIOLOGY (2016)
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
Chao Lu et al.
SCIENCE (2016)
The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability
Kader Salifou et al.
NATURE COMMUNICATIONS (2016)
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
Daniela Bossi et al.
CANCER DISCOVERY (2016)
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia
Li Zhu et al.
CANCER DISCOVERY (2016)
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma
Mouadh Benamar et al.
EBIOMEDICINE (2016)
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice
Shuaiying Cui et al.
BLOOD (2015)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
Functional annotation of native enhancers with a Cas9-histone demethylase fusion
Nicola A. Kearns et al.
NATURE METHODS (2015)
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
John E. Campbell et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
SCFβ-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation
Zhiwei Wang et al.
NATURE COMMUNICATIONS (2015)
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
Daniel Zingg et al.
NATURE COMMUNICATIONS (2015)
NSD1 mutations generate a genome-wide DNA methylation signature
S. Choufani et al.
NATURE COMMUNICATIONS (2015)
Dual Roles of RNF2 in Melanoma Progression
Kunal Rai et al.
CANCER DISCOVERY (2015)
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth
Anthony M. Barsotti et al.
ONCOTARGET (2015)
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells
Theodore Vougiouklakis et al.
ONCOTARGET (2015)
SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells
Lianhua Piao et al.
ONCOTARGET (2015)
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naive patient melanomas
Jonathan J. Lee et al.
CLINICAL EPIGENETICS (2015)
Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date
Daniel P. Mould et al.
MEDICINAL RESEARCH REVIEWS (2015)
EZH2: an emerging role in melanoma biology and strategies for targeted therapy
Jessamy Tiffen et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis
Kuo-Tai Hua et al.
MOLECULAR CANCER (2014)
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia
Fang Cao et al.
MOLECULAR CELL (2014)
Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome
Hans T. Bjornsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin
Anatoly Uzdensky et al.
TUMOR BIOLOGY (2014)
Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression
Youhua Tan et al.
NATURE COMMUNICATIONS (2014)
The Histone-H3K4-Specific Demethylase KDM5B Binds to Its Substrate and Product through Distinct PHD Fingers
Brianna J. Klein et al.
CELL REPORTS (2014)
SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability
Sophia X. Pfister et al.
CELL REPORTS (2014)
JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
Li-Liang Li et al.
BREAST CANCER RESEARCH (2014)
Epigenetic Modifications in Cutaneous Malignant Melanoma
Panagiotis Kampilafkos et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
Guillermo Senisterra et al.
BIOCHEMICAL JOURNAL (2013)
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle et al.
BLOOD (2013)
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
Alexander Roesch et al.
CANCER CELL (2013)
KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors
Joshua C. Black et al.
CELL (2013)
The Histone H3 Methyltransferase G9A Epigenetically Activates the Serine-Glycine Synthesis Pathway to Sustain Cancer Cell Survival and Proliferation
Jane Ding et al.
CELL METABOLISM (2013)
Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2
Hong Wu et al.
FEBS LETTERS (2013)
Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen
Joyce Sayegh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein-Protein Interaction
Hacer Karatas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Division of Labor between the Chromodomains of HP1 and Suv39 Methylase Enables Coordination of Heterochromatin Spread
Bassem Al-Sady et al.
MOLECULAR CELL (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish
Colleen E. Albacker et al.
PLOS ONE (2013)
Semiconductor-based DNA sequencing of histone modification states
Christine S. Cheng et al.
NATURE COMMUNICATIONS (2013)
Pluripotent Stem Cell Protein Sox2 Confers Sensitivity to LSD1 Inhibition in Cancer Cells
Xiaoming Zhang et al.
CELL REPORTS (2013)
LSD1 inhibition: a therapeutic strategy in cancer?
James T. Lynch et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription
David B. Beck et al.
GENES & DEVELOPMENT (2012)
Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4
Hans-Martin Herz et al.
GENES & DEVELOPMENT (2012)
Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2
Weihong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
Laurens Kruidenier et al.
NATURE (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
Enhancer decommissioning by LSD1 during embryonic stem cell differentiation
Warren A. Whyte et al.
NATURE (2012)
Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming
Gaoyang Liang et al.
NATURE CELL BIOLOGY (2012)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K. Knutson et al.
NATURE CHEMICAL BIOLOGY (2012)
Mining Gene Expression Signature for the Detection of Pre-Malignant Melanocytes and Early Melanomas with Risk for Metastasis
Camila Ferreira de Souza et al.
PLOS ONE (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Wenyu Yu et al.
NATURE COMMUNICATIONS (2012)
Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma
Irfan A. Asangani et al.
ONCOTARGET (2012)
KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands
Anca M. Farcas et al.
ELIFE (2012)
Jarid1b targets genes regulating development and is involved in neural differentiation
Sandra U. Schmitz et al.
EMBO JOURNAL (2011)
The diverse functions of Dot1 and H3K79 methylation
Anh Tram Nguyen et al.
GENES & DEVELOPMENT (2011)
Histone H3 trimethylation at lysine 36 is associated with constitutive and facultative heterochromatin
Sophie Chantalat et al.
GENOME RESEARCH (2011)
H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation
Wen Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly
Tsuyoshi Fukuda et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression
Tao Fan et al.
MOLECULAR CANCER RESEARCH (2011)
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Craig J. Ceol et al.
NATURE (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining
Sheema Fnu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Yanqi Chang et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
Luca Sigalotti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Regulation of the Histone H4 Monomethylase PR-Set7 by CRL4cdt2-Mediated PCNA-Dependent Degradation during DNA Damage
Hisanobu Oda et al.
MOLECULAR CELL (2010)
Epigenetic modifications and human disease
Anna Portela et al.
NATURE BIOTECHNOLOGY (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function
Agda Karina Lucio-Eterovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Marta Barradas et al.
GENES & DEVELOPMENT (2009)
The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence
Karl Agger et al.
GENES & DEVELOPMENT (2009)
Chromatin organization marks exon-intron structure
Schraga Schwartz et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Global Repression of Cancer Gene Expression in a Zebrafish Model of Melanoma Is Linked to Epigenetic Regulation
Viviana Anelli et al.
ZEBRAFISH (2009)
Cancer epigenetics: Modifications, screening, and therapy
Einav Nili Gal-Yam et al.
ANNUAL REVIEW OF MEDICINE (2008)
A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse
Gunnar Schotta et al.
GENES & DEVELOPMENT (2008)
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
Paul A. C. Cloos et al.
GENES & DEVELOPMENT (2008)
G9a and HP1 Couple Histone and DNA Methylation to TNFα Transcription Silencing during Endotoxin Tolerance
Mohamed El Gazzar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells
David J. Steger et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b
Jin He et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells
Alexander Roesch et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Tarjei S. Mikkelsen et al.
NATURE (2007)
Expression of polycomb group protein EZH2 in nevi and melanoma
Jonathan B. McHugh et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases - The Myc connection
Julie Secombe et al.
CELL CYCLE (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
Nathaniel D. Heintzman et al.
NATURE GENETICS (2007)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
A trans-tail histone code defined by monomethylated H4 Lys-20 and H3 Lys-9 demarcates distinct regions of silent chromatin
JK Sims et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
D Greiner et al.
NATURE CHEMICAL BIOLOGY (2005)
Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase
JF Couture et al.
GENES & DEVELOPMENT (2005)
Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes
AJ Bannister et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells
S Ait-Si-Ali et al.
EMBO JOURNAL (2004)
Active genes are tri-methylated at K4 of histone H3
H Santos-Rosa et al.
NATURE (2002)
Methylation of histone H3 Lys 4 in coding regions of active genes
BE Bernstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3
SA Jacobs et al.
EMBO JOURNAL (2001)
Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression
D O'Carroll et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
